M
Mustafa A. Arain
Researcher at University of California, San Francisco
Publications - 111
Citations - 2805
Mustafa A. Arain is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 71 publications receiving 1732 citations. Previous affiliations of Mustafa A. Arain include University of Southern California & City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Al B. Benson,Alan P. Venook,Mahmoud M. Al-Hawary,Mustafa A. Arain,Yi Jen Chen,Kristen K. Ciombor,Stacey Cohen,Harry S. Cooper,Dustin A. Deming,Linda Farkas,Ignacio Garrido-Laguna,Jean L. Grem,Andrew J. Gunn,J. Randolph Hecht,Sarah E. Hoffe,Joleen M. Hubbard,Steven C. Hunt,Kimberly L. Johung,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Jeffrey A. Meyerhardt,Eric D. Miller,Mary F. Mulcahy,Steven J. Nurkin,Michael J. Overman,Aparna Raj Parikh,Hitendra Patel,Katrina S. Pedersen,Leonard B. Saltz,Charles Schneider,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Kristina M. Gregory,Lisa A. Gurski +38 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section as discussed by the authors.
Journal ArticleDOI
CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle
Mustafa A. Arain,Mandeep S. Sawhney,Shehla Sheikh,Ruth Anway,Bharat Thyagarajan,John H. Bond,Aasma Shaukat +6 more
TL;DR: Interval cancers are more likely to arise in the proximal colon and demonstrate CIMP, which suggests there may be differences in biology between these and non-interval CRC.
Journal ArticleDOI
Rectal cancer, version 6.2020: Featured updates to the NCCN guidelines
Al B. Benson,Al B. Benson,Alan P. Venook,Alan P. Venook,Mahmoud M. Al-Hawary,Mahmoud M. Al-Hawary,Mustafa A. Arain,Mustafa A. Arain,Yi Jen Chen,Yi Jen Chen,Kristen K. Ciombor,Kristen K. Ciombor,Stacey Cohen,Stacey Cohen,Harry S. Cooper,Harry S. Cooper,Dustin A. Deming,Dustin A. Deming,Ignacio Garrido-Laguna,Ignacio Garrido-Laguna,Jean L. Grem,Jean L. Grem,Andrew Gunn,Sarah E. Hoffe,Sarah E. Hoffe,Joleen M. Hubbard,Joleen M. Hubbard,Steven C. Hunt,Steven C. Hunt,Natalie Kirilcuk,Natalie Kirilcuk,Smitha S. Krishnamurthi,Smitha S. Krishnamurthi,Wells A. Messersmith,Wells A. Messersmith,Jeffrey A. Meyerhardt,Jeffrey A. Meyerhardt,Eric D. Miller,Eric D. Miller,Mary F. Mulcahy,Mary F. Mulcahy,Steven J. Nurkin,Steven J. Nurkin,Michael J. Overman,Michael J. Overman,Aparna Raj Parikh,Aparna Raj Parikh,Hitendra Patel,Hitendra Patel,Katrina S. Pedersen,Katrina S. Pedersen,Leonard Saltz,Leonard Saltz,Charles Schneider,Charles Schneider,David Shibata,David Shibata,John M. Skibber,John M. Skibber,Constantinos T. Sofocleous,Constantinos T. Sofocleous,Elena M. Stoffel,Elena M. Stoffel,Eden Stotsky-Himelfarb,Eden Stotsky-Himelfarb,Christopher G. Willett,Christopher G. Willett,Alyse Johnson-Chilla,Alyse Johnson-Chilla,Lisa A. Gurski,Lisa A. Gurski +70 more
TL;DR: These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, clarifying the definition of rectum and differentiating the rectum from the sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer.
Journal ArticleDOI
Factors Predicting Outcomes After a Total Pancreatectomy and Islet Autotransplantation Lessons Learned From Over 500 Cases.
Srinath Chinnakotla,Gregory J. Beilman,Ty B. Dunn,Melena D. Bellin,Martin L. Freeman,David M. Radosevich,Mustafa A. Arain,Stuart K. Amateau,J. Shawn Mallery,Sarah Jane Schwarzenberg,Alfred L. Clavel,Joshua J. Wilhelm,R. Paul Robertson,Louise Berry,Marie Cook,Bernhard J. Hering,David E.R. Sutherland,Timothy L. Pruett +17 more
TL;DR: This article represents the largest study of factors predicting outcomes after a total pancreatectomy and islet autotransplantation (TP-IAT) and noted a strong dose-response relationship between the lowest-yield category (<2000 IEQ) and the highest (≥5000 IEQ or more).
Journal ArticleDOI
Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson,Alan P. Venook,Mahmoud M. Al-Hawary,Mustafa A. Arain,Yi Jen Chen,Kristen K. Ciombor,Stacey Cohen,Harry S. Cooper,Dustin A. Deming,Ignacio Garrido-Laguna,Jean L. Grem,Sarah E. Hoffe,Joleen M. Hubbard,Steven C. Hunt,Ahmed Kamel,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Jeffrey A. Meyerhardt,Eric D. Miller,Mary F. Mulcahy,Ms Steven Nurkin Nurkin,Michael J. Overman,Aparna Raj Parikh,Hitendra Patel,Katrina S. Pedersen,Leonard B. Saltz,Charles Schneider,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Alyse Johnson-Chilla,Kristina M. Gregory,Lisa A. Gurski +36 more
TL;DR: The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA and provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease.